Navigation Links
epratuzumab in Medical News

Adding epratuzumab to standard therapy

ROCHESTER, Minn. -- Adding a second monoclonal antibody drug to chemotherapy looks promising for treatment of diffuse large B-cell lymphoma, according to Mayo Clinic researchers working with the North Central Cancer Treatment Group (NCCTG) ( http://ncctg.mayo.edu/ ). Results of this interim analys...

Two Targeted Therapies Likely Better Than One in Patients with Aggressive Lymphoma, Mayo Clinic Researchers Say

..., researchers say that adding the targeted therapy epratuzumab to a regimen known as R-CHOP resulted in an overal...researchers are the first to study the addition of epratuzumab to R-CHOP in newly diagnosed, untreated patients. Both epratuzumab and rituximab are monoclonal antibodies that attac...

Two targeted therapies likely better than one in patients with aggressive lymphoma

..., researchers say that adding the targeted therapy epratuzumab to a regimen known as R-CHOP resulted in an overal...researchers are the first to study the addition of epratuzumab to R-CHOP in newly diagnosed, untreated patients. Both epratuzumab and rituximab are monoclonal antibodies that attac...

Immunomedics to Present at 27th Annual J.P. Morgan Healthcare Conference

...pment (including clinical trials outcome and regulatory requirements/actions), our dependence on our licensing partners for the further development of epratuzumab for autoimmune indications and veltuzumab for non-cancer indications, competitive risks to marketed products and availability of required financing an...
epratuzumab in Medical Technology

Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus

Encouraging Clinical Data Presented at American College of Rheumatology (ACR) meeting Show Reduced Need for Concomitant Corticosteroid Therapy SAN FRANCISCO, Oct. 27 /PRNewswire-FirstCall/ -- UCB (Euronext Brussels: UCB) announced data from two randomized controlled trials showing that treat...

Promising Results with Epratuzumab and Chemotherapy in Children with Acute Lymphoblastic Leukemia

- Results from a Children's Oncology Group (COG) Study Presented at American Society of Clinical Oncology Annual Meeting - CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- Immunomedics, Inc. , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious...

Immunomedics Announces Preclinical Therapy Results of SN-38 Immunoconjugate for Colorectal Cancer

...pment (including clinical trials outcome and regulatory requirements/actions), our dependence on our licensing partners for the further development of epratuzumab for autoimmune indications and veltuzumab for non-cancer indications, competitive risks to marketed products and availability of required financing an...

Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and Effective in Colorectal Cancer with Liver Metastases

...cations worldwide. We have retained the rights for epratuzumab in oncology indications for which UCB has been gra... is responsible for all clinical trials evaluating epratuzumab for the treatment of patients with moderate and se...with hA20 in patients with non-Hodgkin's lymphoma, epratuzumab as a potential therapeutic for patients with lymph...

Immunomedics Reports Initial Clinical Results With Hpam4 For Pancreatic Cancer Therapy

...cations worldwide. We have retained the rights for epratuzumab in oncology indications for which UCB has been gra... is responsible for all clinical trials evaluating epratuzumab for the treatment of patients with moderate and se...with hA20 in patients with non-Hodgkin's lymphoma, epratuzumab as a potential therapeutic for patients with lymph...

Fractionated Radioimmunotherapy With (90)Y-epratuzumab in Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II Study

...treated with a new radioimmunotherapy (RAIT) using epratuzumab to deliver toxic radiation directly to lymphoma ce...ll tumors as expressed by NHL cells. Immunomedics' epratuzumab is a humanized monoclonal antibody that targets th...cations worldwide. We have retained the rights for epratuzumab in oncology indications for which UCB has been gra...
Other Tags
(Date:9/17/2014)... September 18, 2014 The global ablation ... of 9.6% from 2014 to 2019. Although mature markets ... hold larger shares in the ablation technologies market in ... the highest CAGR of 12.8% in the next five ... healthcare infrastructure, growing number of hospitals and surgical centers, ...
(Date:9/17/2014)... September 18, 2014 Recently, UWDress.com, an ... and women’s special occasion outfits, has released its 2014 ... addition, the firm has launched a big sale for ... now available at deeply discounted rates, from 15 to ... the company insists on using comfortable to wear materials. ...
(Date:9/17/2014)... A ball gown is the most formal ... full-skirted gown reaching the floor, made of luxurious fabric, ... occasion gown manufacturer and retailer, has delightedly unveiled its ... gowns are offered at discounted rates. , Most versions ... gowns are typically worn with a stole (a formal ...
(Date:9/17/2014)... IntimateRider, an inventor of classy sexual enhancement ... it has entered into a dealership agreement with new ... reason for the deal is the fact that All ... its sales potential, representatives at the mobility products firm ... latest products on the market both nationally and internationally." ...
(Date:9/17/2014)... Dr. Shalev is a Texas native, and grew ... at the University of Texas, and graduated with a Bachelors ... real passion lay in dentistry, and she went on to ... Texas Health Science Center at Houston School of Dentistry. Dr. ... of The Greater Houston Dental Society, and the Texas Dental ...
Breaking Medicine News(10 mins):Health News:9.6% CAGR for Ablation Technologies Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 2Health News:9.6% CAGR for Ablation Technologies Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 3Health News:9.6% CAGR for Ablation Technologies Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 4Health News:2014 Empire Waist Evening Dress Collection Now Unveiled At UWDress.com 2Health News:Fecbek.com: Ladies Can Be Elegant Enough to Draw Everyone’s Attention by Wearing Trendy Ball Gowns 2Health News:IntimateRider Announces All Terrain Medical & Mobility as Its New Dealer 2Health News:IntimateRider Announces All Terrain Medical & Mobility as Its New Dealer 3
(Date:9/17/2014)... 17, 2014) A rare genetic disorder known as Jacobsen ... recent joint investigation by researchers at San Diego State ... addition to suggesting better treatment options for people with ... the genetic underpinnings of autism., Jacobsen syndrome affects approximately ... of Health. It occurs in a person when there ...
(Date:9/17/2014)... team of Spanish researchers have obtained the first partial ... sixteenth century pig found at the site of the ... this ancient pig is closely related to today,s Iberian ... were crossed with modern Iberian pigs. , The study, ... evolutionary aspects of pig species, and particularly on that ...
(Date:9/17/2014)... After decades of decline, grasses have returned to ... eye, the marsh in those places seems healthy again, ... service of the marsh coastal protection remains ... ecosystem function hasn,t come back," said ecologist Mark Bertness, ... the study in the journal Biological Conservation . ...
Breaking Biology News(10 mins):A link between Jacobsen syndrome and autism 2Iberian pig genome remains unchanged after 5 centuries 2Cape Cod saltmarsh recovery looks good, falls short 2Cape Cod saltmarsh recovery looks good, falls short 3
Other Contents